Daiichi Sankyo and AstraZeneca’s Enhertu Plus Pertuzumab Approved in China for First-Line HER2+ Metastatic Breast Cancer
FDA is Announcing an Upcoming Meeting
Financial Toxicity in Cancer Care: A Global Call for Submissions
Medical Oncology vs Radiation Oncology: Who Does What in Cancer Care?
Shane Jacobson: New $5.45 Million Fund to Empower the Next Generation of Cancer Scientists
Alejandra Mendez Highlights the Impact of the Zero Abandonment Programme in Childhood Cancer
Julie Gralow on Why Federal Funding Matters for the Future of Cancer Research
ctDNA in Early Breast Cancer: Powerful Promise, Key Gaps
The ESMO Advanced Course on Precision Treatment Sequencing in Metastatic Breast Cancer 2026, organized by the European Society for Medical Oncology (ESMO), will take place on 2–3 October 2026 in Singapore. The course will focus on treatment sequencing, the biology of metastatic breast cancer, targeted therapy safety and adverse-event management, and multidisciplinary approaches to improving […]
The ESMO Advanced Course on Optimising Treatment Sequencing in Advanced NSCLC 2026, oorganized by the European Society for Medical Oncology (ESMO), will take place on 2–3 October 2026 in Singapore. The course will focus on sequencing strategies for actionable genomic alteration-positive NSCLC, biomarker-driven treatment using NGS, immunohistochemistry, and liquid biopsy, and emerging therapies such as […]
